Fosinopril Attenuates the Doxorubicin-induced Cardiomyopathy by Restoring the Function of Sarcoplasmic Reticulum

Cell Biochemistry and Biophysics

Volumn 64, Issue 3, 2012, Pages 205-211

  Zhang, Ya chen ^a   Tang, Yong ^a   Zhang, Min ^a   Chen, Jian ^a   Zhou, Qing ^a   Sun, Ying gang ^a   Chen, Man tian ^a   Xu, Wei ping ^a  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

Cardiomyopathy; Doxorubicin; Fosinopril; Heart failure; Sarcoplasmic reticulum; Toxicity

Indexed keywords

RATTUS;

EID: 84869093126     PISSN: 10859195     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12013-012-9386-6     Document Type: Article

References (33)

1. Nakamura, T., Ueda, Y., Juan, Y., Katsuda, S., Takahashi, H., & Koh, E. (2000). Fas-mediated apoptosis in adriamycin-induced cardiomyopathy in rats: In vivo study. Circulation, 102, 572-578.
2. 2+ increase are reciprocally modulated in rat cardiomyocytes. Experimental and Molecular Medicine, 38, 535-545.
3. Olson, R. D., Gambliel, H. A., Vestal, R. E., Shadle, S. E., Charlier, H. A., Jr, & Cusack, B. J. (2005). Doxorubicin cardiac dysfunction: effects on calcium regulatory proteins, sarcoplasmic reticulum, and triiodothyronine. Cardiovascular Toxicology, 5, 269-283.
4. Ondrias, K., Borgatta, L., Kim, D. H., & Ehrlich, B. E. (1990). Biphasic effects of doxorubicin on the calcium release channel from sarcoplasmic reticulum of cardiac muscle. Circulation Research, 67, 1167-1174.
5. Dhalla, N. S., Shao, Q., & Panagia, V. (1998). Remodeling of cardiac membranes during the development of congestive heart failure. Heart Failure Reviews, 2, 261-272.
6. Kim, E., Giri, S. N., & Pessah, I. N. (1995). Iron(II) is a modulator of ryanodine-sensitive calcium channels of cardiac muscle sarcoplasmic reticulum. Toxicology and Applied Pharmacology, 130, 57-66.
7. Lachnit, W. G., Phillips, M., Gayman, K. J., & Pessah, I. N. (1994). Ryanodine and dihydropyridine binding patterns and ryanodine receptor mRNA levels in myopathic hamster heart. American Journal of Physiology, 267, H1205-H1213.
8. 2+ transport proteins and the effect of taurine on myocardial protection in rabbits. Journal of Zhejiang University-Science, 4, 114-120.
9. Boateng, S. Y., Seymour, A. M., Bhutta, N. S., Dunn, M. J., Yacoub, M. H., & Boheler, K. R. (1998). Sub-antihypertensive doses of ramipril normalize sarcoplasmic reticulum calcium ATPase expression and function following cardiac hypertrophy in rats. Journal of Molecular and Cellular Cardiology, 30, 2683-2694.
10. Guo, X., Chapman, D., & Dhalla, N. S. (2003). Partial prevention of changes in SR gene expression in congestive heart failure due to myocardial infarction by enalapril or losartan. Molecular and Cellular Biochemistry, 254, 163-172.
11. 2+ transport and gene expression in congestive heart failure are modified by imidapril treatment. American Journal of Physiology-Heart and Circulatory Physiology, 288, H1674-H1682.
12. Dhalla, N. S., Wang, S., & Beamish, R. E. (1996). Intracellular calcium handling in normal and failing hearts. Experimental & Clinical Cardiology, 1, 7-20.
13. Siveski-Iliskovic, N., Kaul, N., & Singal, P. K. (1994). Probucol promotes endogenous antioxidants and provides protection against adriamycin-induced cardiomyopathy in rats. Circulation, 89, 2829-2835.
14. Ganguly, P. K., Pierce, G. N., Dhalla, K. S., & Dhalla, N. S. (1983). Defective sarcoplasmic reticular calcium transport in diabetic cardiomyopathy. American Journal of Physiology, 244, E528-E535.
15. Afzal, N., & Dhalla, N. S. (1992). Differential changes in left and right ventricular SR calcium transport in congestive heart failure. American Journal of Physiology, 262, H868-H874.
16. Fabiato, A. (1988). Computer programs for calculating total from specified free or free from specified total ionic concentrations in aqueous solutions containing multiple metals and ligands. Methods in Enzymology, 157, 378-417.
17. Laemmli, U. K. (1970). Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature, 227, 680-685.
18. Shaker, O., & Sourour, D. A. (2010). How to protect doxorubicin-induced cardiomyopathy in male albino rats? Journal of Cardiovascular Pharmacology, 55, 262-268.
19. Richard, C., Lauzier, B., Delemasure, S., Talbot, S., Ghibu, S., Collin, B., et al. (2008). Effects of angiotensin-1 converting enzyme inhibition on oxidative stress and bradykinin receptor expression during doxorubicin-induced cardiomyopathy in rats. Journal of Cardiovascular Pharmacology, 52, 278-285.
20. Soga, M., Kamal, F. A., Watanabe, K., Ma, M., Palaniyandi, S., Prakash, P., et al. (2006). Effects of angiotensin II receptor blocker (candesartan) in daunorubicin-induced cardiomyopathic rats. International Journal of Cardiology, 110, 378-385.
21. Georgakopoulos, P., Roussou, P., Matsakas, E., Karavidas, A., Anagnostopoulos, N., Marinakis, T., et al. (2010). Cardioprotective effect of metoprolol and enalapril in doxorubicin-treated lymphoma patients: A prospective, parallel-group, randomized, controlled study with 36-month follow-up. American Journal of Hematology, 85, 894-896.
22. Blaes, A. H., Gaillard, P., Peterson, B. A., Yee, D., & Virnig, B. (2010). Angiotensin converting enzyme inhibitors may be protective against cardiac complications following anthracycline chemotherapy. Breast Cancer Research and Treatment, 122, 585-590.
23. Nakamae, H., Tsumura, K., Terada, Y., Nakane, T., Nakamae, M., Ohta, K., et al. (2005). Notable effects of angiotensin II receptor blocker, valsartan, on acute cardiotoxic changes after standard chemotherapy with cyclophosphamide, doxorubicin, vincristine, and prednisolone. Cancer, 104, 2492-2498.
24. Kim, H. J., Ryu, J. H., Han, S. W., Park, I. K., Paik, S. S., Park, M. H., et al. (2004). Combined therapy of cilazapril and losartan has no additive effects in ameliorating adriamycin-induced glomerulopathy. Nephron Physiology, 97, 58-65.
25. Hiona, A., Lee, A. S., Nagendran, J., Xie, X., Connolly, A. J., Robbins, R. C., et al. (2011). Pretreatment with angiotensin-converting enzyme inhibitor improves doxorubicin-induced cardiomyopathy via preservation of mitochondrial function. Journal of Thoracic and Cardiovascular Surgery, 142, 396-403.
26. 2: Evidence for enhanced toxicity with multiagent chemotherapy. American Journal of Hematology, 1991(36), 217-218.
27. Kim, D. H., Landry, A. B., I. I. I., Lee, Y. S., & Katz, A. M. (1989). Doxorubicin-induced calcium release from cardiac sarcoplasmic reticulum vesicles. Journal of Molecular and Cellular Cardiology, 21, 433-436.
28. Chamberlain, B. K., & Fleischer, S. (1988). Isolation of canine cardiac sarcoplasmic reticulum. Methods in Enzymology, 157, 91-99.
29. Feldman, A. M., Weinberg, E. O., Ray, P. E., & Lorell, B. H. (1993). Selective changes in cardiac gene expression during compensated hypertrophy and the transition to cardiac decompensation in rats with chronic aortic banding. Circulation Research, 73, 184-192.
30. Arai, M., & Matsui, H. (1994). Sarcoplasmic reticulum gene expression in cardiac hypertrophy and heart failure. Circulation Research, 74, 555-564.
31. Hasenfuss, G., Reinecke, H., Studer, R., Meyer, M., Pieske, B., Holtz, J., et al. (1994). Relation between myocardial function and expression of sarcoplasmic reticulum Ca(2+)-ATPase in failing and nonfailing human myocardium. Circulation Research, 75, 434-442.
32. Takeishi, Y., Bhagwat, A., Ball, N. A., Kirkpatrick, D. L., Periasamy, M., & Walsh, R. A. (1999). Effect of angiotensin-converting enzyme inhibition on protein kinase C and SR proteins in heart failure. American Journal of Physiology, 276, H53-H62.
33. Lompre, A. M., Anger, M., & Levitsky, D. (1994). Sarco(endo)plasmic reticulum calcium pumps in the cardiovascular system: Function and gene expression. Journal of Molecular and Cellular Cardiology, 26, 1109-1121.